Inventiva Pharma
Biopharmaceutical company specialising in nuclear receptors, transcription factors, and epigenetic modulation. Learn more
Launch date
Employees
Market cap
€110m
Enterprise valuation
€121m (Public information from Sep 2024)
Share price
$2.11 IVA
Company register number 537530255
Daix Bourgogne-Franche-Comté (HQ)
Authorizing premium user...